Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

942 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY. Ichikawa J, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2002 Mar;26(3):325-39. doi: 10.1016/S0893-133X(01)00312-8. Neuropsychopharmacology. 2002. PMID: 11850147
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.
Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, Sanders-Bush E. Niswender CM, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2001 May;24(5):478-91. doi: 10.1016/S0893-133X(00)00223-2. Neuropsychopharmacology. 2001. PMID: 11282248
5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J, Dai J, Meltzer HY. Ichikawa J, et al. Among authors: meltzer hy. Brain Res. 2002 Jun 7;939(1-2):34-42. doi: 10.1016/s0006-8993(02)02544-1. Brain Res. 2002. PMID: 12020849
Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, Levy UH, Meltzer HY, Kennedy JL, Steen VM, Macciardi F. Lerer B, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2002 Jul;27(1):105-19. doi: 10.1016/S0893-133X(02)00293-2. Neuropsychopharmacology. 2002. PMID: 12062911
Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
Meltzer HY, Davidson M, Glassman AH, Vieweg WV. Meltzer HY, et al. J Clin Psychiatry. 2002;63 Suppl 9:25-9. J Clin Psychiatry. 2002. PMID: 12088173 Review.
Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.
Meltzer HY. Meltzer HY. Curr Psychiatry Rep. 2002 Aug;4(4):279-83. doi: 10.1007/s11920-996-0047-6. Curr Psychiatry Rep. 2002. PMID: 12126596 Review.
5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
LiƩgeois JF, Ichikawa J, Meltzer HY. LiƩgeois JF, et al. Among authors: meltzer hy. Brain Res. 2002 Aug 30;947(2):157-65. doi: 10.1016/s0006-8993(02)02620-3. Brain Res. 2002. PMID: 12176156
Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
Meltzer HY. Meltzer HY. Psychopharmacology (Berl). 2002 Aug;163(1):1-3. doi: 10.1007/s00213-002-1088-0. Epub 2002 Jul 5. Psychopharmacology (Berl). 2002. PMID: 12185394 No abstract available.
SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S, Meltzer HY, Li Z, Dai J, Alboszta AR, Ichikawa J. Bonaccorso S, et al. Among authors: meltzer hy. Neuropsychopharmacology. 2002 Sep;27(3):430-41. doi: 10.1016/S0893-133X(02)00311-1. Neuropsychopharmacology. 2002. PMID: 12225700
The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.
Sumiyoshi T, Jayathilake K, Meltzer HY. Sumiyoshi T, et al. Among authors: meltzer hy. Schizophr Res. 2003 Jan 1;59(1):7-16. doi: 10.1016/s0920-9964(01)00329-2. Schizophr Res. 2003. PMID: 12413636 Clinical Trial.
942 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback